by Keishi Foecke | Mar 5, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Feb 26, 2025 | Blog Post
Competition policies that support pro-competitive mergers and acquisitions (M&A) are critical to fueling innovation, competition and growth in America’s life sciences industry. Importantly, M&A has a quantifiable impact for the ecosystem and for the thousands...
by Keishi Foecke | Feb 19, 2025 | Blog Post
During a recent panel discussion at the 2024 National Lawyers Convention, leading antitrust experts underscored the impact of recent policy shifts from the Federal Trade Commission (FTC) and Department of Justice (DOJ). In America’s life sciences ecosystem, the FTC...
by Keishi Foecke | Feb 13, 2025 | Blog Post
This week, PULSE joined over 35 leading business and industry stakeholders in calling for leaders of the House Judiciary Committee to overturn the Biden Administration’s Hart-Scott-Rodino (HSR) premerger notification rule changes. In their letter to the Committee, the...
by Keishi Foecke | Feb 6, 2025 | Blog Post
It’s critical that competition policies reflect the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. Policies that support pro-competitive life sciences M&A can help drive growth, incentivize investment and,...
by Keishi Foecke | Feb 4, 2025 | Blog Post, PULSE Partner
In a recent op-ed for NJBIZ, Debbie Hart, President and CEO of PULSE Partner BioNJ, discusses how federal policy against mergers and acquisitions (M&A) could undermine New Jersey’s leadership in the life sciences. Read the op-ed below: As the “medicine chest of...
